- In 2022, Roivant Sciences, in collaboration with Pfizer, launched RVT-3101 to tackle ulcerative colitis. Roivant retains commercial rights in the U.S. and Japan, while Pfizer oversees commercialization elsewhere. This partnership aims to combat the global impact of ulcerative colitis through joint commercial efforts
- In 2022, JB Pharma unveiled Ranraft, a novel treatment for gastroesophageal reflux disease (GERD), bolstering its position in gastroenterology. This strategic launch expands JB Pharma's product portfolio and underscores its dedication to innovative digestive health solutions, catering to the needs of GERD sufferers
- In 2021, Purdue Pharma L.P. introduced two Senokot Dietary Supplement Products. Senokot Laxative Gummies, in blueberry pomegranate flavor, offer gentle overnight relief for constipation with natural senna extract. Senokot Laxative Tea, infused with cinnamon and floral notes, diversifies their digestive health offerings
- In 2020, FDA approved lactitol for chronic idiopathic constipation treatment in adults. As a powder, lactitol offers flexibility in administration and is easily mixed with water or juice for enhanced patient convenience. This approval broadens treatment options, providing a versatile solution for chronic constipation sufferers
